Associated Papers
Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer.
Lotan TL et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2021
33462368 (PubMed )
Supplement: NIHMS1655161-supplement-1.pdf
Bilateral Disease Common Among Slovenian CHEK2-Positive Breast Cancer Patients.
Nizic-Kos T et al.
Annals of Surgical Oncology, 2021
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers.
Toss A et al.
Genes, 2021
The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants.
Schubert S et al.
International Journal of Cancer, 2019
Use of multigene-panel identifies pathogenic variants in several CRC-predisposing genes in patients previously tested for Lynch Syndrome.
Hansen MF et al.
Clinical Genetics, 2017
Select a paper to view details